https://orcid.org/0000-0002-1974-2536
Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Evdoxia-Maria Karasavvidou, Paris Tranos & Georgios D Panos. (2022) Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies. Drug Design, Development and Therapy 16, pages 2659-2680.
Read now
Read now
Articles from other publishers (2)
Sanjay Kumar Mishra, Pradeep Kumar, Srishti Khullar, Amrita Joshi, Alok Sati, Sonali Vinay Kumar, Deepesh Unni & Atul Kumar. (2022) Efficacy and safety of brolucizumab versus aflibercept in patients with neovascular age-related macular degeneration: a randomized trial in Indian patients. International Journal of Retina and Vitreous 8:1.
Crossref
Crossref
Natacha C. Villegas, Kapil Mishra, Nathan Steinle, Wu Liu, Beth Beadle & Prithvi Mruthyunjaya. (2022) Intravitreal brolucizumab as treatment of early onset radiation retinopathy secondary to plaque brachytherapy for choroidal melanoma. American Journal of Ophthalmology Case Reports 27, pages 101581.
Crossref
Crossref